Arca Biopharma | ABIO - Ebitda





Ebitda Alterar Data
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 3.86B 1.28B 2026-03
Arca Biopharma USD -25.07M 5.23M 2025-03
Biogen USD 649.7M 76.5M 2026-03
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Cipla INR 14.03B 4.48B 2026-06
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -9.02M 1.12M 2026-03
CSL USD 3.13B 1.17B 2025-12
Cytokinetics USD -169.32M 19.48M 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Grifols EUR 482.04M 7.04M 2025-09
Laboratory Of America USD 767.7M 162.1M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
Otsuka Holdings JPY 156.66B 56.89B 2026-03
Pfizer USD 6.01B 18M 2026-06
United Therapeutics USD 355M 11.1M 2026-06